Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
about
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersConstitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohortMeta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolismPolymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypesExpression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue.Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications.Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Characterizing Genetic Susceptibility to Breast Cancer in Women of African Ancestry.Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.Gene-environment interactions involving functional variants: Results from the Breast Cancer Association Consortium.Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Enhancing the Promise of Drug Repositioning through Genetics.Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes.A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression.Common Genetic Variation and Breast Cancer Risk - Past, present, and future.Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study.Capture Hi-C identifies putative target genes at 33 breast cancer risk loci.Genetic variation in sensitivity to estrogens and breast cancer risk.Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS AnalysesComplex genetics of female fertilityExploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian CancerVariants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits
P2860
Q33614244-7225D141-449E-42C3-9668-317CE148FC0FQ33731346-0A992733-9107-40CF-A265-E9AB253426E5Q33761264-DA9D91E1-43AF-42D5-AB0C-25DF56ED211FQ36158021-4B4ADF96-4201-40D7-A129-D626158CEB38Q36267818-21380CC2-F4C4-425C-A80F-C3C9B0783A9FQ36356727-0BEAA467-6129-4EDA-919B-26A5108D1E9AQ37164587-D7A78504-D82F-4ED9-91F7-B0F64E83DBBFQ37297706-DF8751C9-EF09-4AFD-87F9-833D4213C3BCQ37342144-D4406EAB-689E-46B6-8E14-B82D463D8947Q39002074-BF0A4566-0DEA-4147-B216-DBD912E3FD12Q39045823-8F8FA290-1B48-4FF4-BCFE-7ADBCC12CE17Q40137431-CF056937-4FB6-4BE5-ABB6-A3712962CEF6Q41011976-297B8FDD-2FC7-4CBB-9F52-BCA4C31A7A0FQ46103372-203C7869-A18C-43D0-A7B8-18830D3921B5Q47095277-C14A0C66-348F-4191-A6E9-DD20067E4948Q47343843-E2052A0A-CEBE-42BA-87A5-09E2243D421EQ47620193-503A42A0-4915-441E-BF2B-32ADA578D662Q47703662-010B860C-D8E3-415A-A767-71AE5F910D4FQ50046604-F07F64B4-F1FD-4643-A973-8760CA437B00Q55064805-064D3A3A-D5C4-4161-9C17-473E17AAD903Q55521896-4661017A-8B1B-42F6-B42C-839318B7C80DQ57108215-B2934F01-7927-4DCD-A750-417C7D64A4F1Q57560926-38A93F8E-B1E9-4199-87E9-7AFAE3AA1665Q58704255-94A04E84-4C21-44F6-A6C8-554C2E7065E0Q58759681-E5D9959F-39A6-47B8-82E4-058F3B9FF454
P2860
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@ast
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@en
type
label
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@ast
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@en
prefLabel
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@ast
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@en
P2093
P2860
P50
P356
P1433
P1476
Breast cancer risk variants at ...... ulate ESR1, RMND1 and CCDC170.
@en
P2093
Anders Bojesen
Andrew K Godwin
Andrew Lee
Anna von Wachenfeldt
Ans M W van den Ouweland
Banu K Arun
Barbara J Perkins
P2860
P2888
P304
P356
10.1038/NG.3521
P407
P50
P577
2016-02-29T00:00:00Z